GHRP-6 · research summary

Changes in Locomotor Activity Observed During Acute Nicotine Withdrawal Can Be Attenuated by Ghrelin and GHRP-6 in Rats.

Biomedicines · 2025. Summary drawn from the study's full text. Each statement is followed by the exact sentence it comes from. This is a research summary, not medical advice.

Study type

Experimental study investigating impacts of ghrelin and GHRP-6 on activity in rats exposed to chronic nicotine and withdrawal
“The present study aimed to investigate the impacts of ghrelin and GHRP-6 on the horizontal and vertical activity in rats exposed to chronic nicotine treatment followed by acute nicotine withdrawal.”

Subjects

Male and female adolescent Wistar rats
“The male and female Wistar rats used were provided by Toxi-Coop, Toxicological Research Center Zrt., Budapest, Hungary (N = 97).”

Sample size

97 rats initially, with 3 excluded due to cannula placement issues
“The male and female Wistar rats used were provided by Toxi-Coop, Toxicological Research Center Zrt., Budapest, Hungary (N = 97).”

Duration

7 days of treatment followed by activity monitoring on days 8 and 9
“Male and female Wistar rats were exposed daily to intraperitoneal (ip) injection with 2 mg/kg nicotine or saline solution for 7 days, twice a day (at 8:00 and at 20:00).”

Reported findings

Nicotine-treated rats showed significant hyperactivity on day 8, reduced by ghrelin and GHRP-6
“On the eighth day, in nicotine-treated rats a significant hyperactivity was observed, that was reduced significantly by ghrelin and GHRP-6.”
Nicotine-treated rats showed significant hypoactivity on day 9, reversed by ghrelin and GHRP-6
“On the ninth day, in nicotine-treated rats a significant hypoactivity was assessed that was reversed significantly by ghrelin and GHRP-6.”
Effects of ghrelin and GHRP-6 on horizontal activity were significant in both sexes on day 9
“This time, when the rats were separated in two groups, the horizontal activity decreased significantly in both males (F(5,25) = 7.94; p < 0.001) and females (F(5,20) = 12.05; p < 0.001) treated with nicotine, and subsequently, the effects of ghrelin and GHRP-6 were significant in both sexes (Figure 5).”

Limitations stated by the authors

Small sample size after sex separation, lack of blood nicotine/cotinine measurements, and limited observation time points
“In addition to the relatively small sample size of the male and female groups after separation, our study may also have other limitations [87].”

Source: PubMed 39857727 · DOI 10.3390/biomedicines13010143 · all study summaries

Study type

Experimental study investigating impacts of ghrelin and GHRP-6 on activity in rats exposed to chronic nicotine and withdrawal

“The present study aimed to investigate the impacts of ghrelin and GHRP-6 on the horizontal and vertical activity in rats exposed to chronic nicotine treatment followed by acute nicotine withdrawal.”

Reported findings

Nicotine-treated rats showed significant hyperactivity on day 8, reduced by ghrelin and GHRP-6

“On the eighth day, in nicotine-treated rats a significant hyperactivity was observed, that was reduced significantly by ghrelin and GHRP-6.”

Nicotine-treated rats showed significant hypoactivity on day 9, reversed by ghrelin and GHRP-6

“On the ninth day, in nicotine-treated rats a significant hypoactivity was assessed that was reversed significantly by ghrelin and GHRP-6.”

Effects of ghrelin and GHRP-6 on horizontal activity were significant in both sexes on day 9

“This time, when the rats were separated in two groups, the horizontal activity decreased significantly in both males (F(5,25) = 7.94; p < 0.001) and females (F(5,20) = 12.05; p < 0.001) treated with nicotine, and subsequently, the effects of ghrelin and GHRP-6 were significant in both sexes (Figure 5).”